SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-212598
Filing Date
2019-08-05
Accepted
2019-08-05 09:21:34
Documents
63
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d773542d10q.htm 10-Q 384136
2 EX-10.4 d773542dex104.htm EX-10.4 277762
3 EX-31.1 d773542dex311.htm EX-31.1 10074
4 EX-31.2 d773542dex312.htm EX-31.2 10351
5 EX-32.1 d773542dex321.htm EX-32.1 4305
  Complete submission text file 0001193125-19-212598.txt   4016288

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pulm-20190630.xml EX-101.INS 835989
7 XBRL TAXONOMY EXTENSION SCHEMA pulm-20190630.xsd EX-101.SCH 40929
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pulm-20190630_cal.xml EX-101.CAL 33039
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pulm-20190630_def.xml EX-101.DEF 151416
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pulm-20190630_lab.xml EX-101.LAB 308868
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pulm-20190630_pre.xml EX-101.PRE 256008
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36199 | Film No.: 19997721
SIC: 2834 Pharmaceutical Preparations